Phase II study of decitabine and gemtuzumab ozogamicin (GO) in acute myelogenous leukemia (AML) and high-risk myelodysplastic syndrome (MDS). Background: CML patients with different types of BCR-ABL ...
Functional status of neuroendocrine tumors among elderly patients: A large population-based study using SEER-Medicare data. This is an ASCO Meeting Abstract from the 2016 ASCO Annual Meeting I. This ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果